Diagnosis of lung cancer - soon with a simple breathing tube
20 August 2014, 16:30
Researchers at the Tel Aviv University in Israel, together with foreign partners, have developed an innovative apparatus for detecting lung cancer at its earliest stages. Lung cancer is known to be high, in relation to other types of cancer, the death rate. The reason for this is the fact that the disease manifests itself and gives the patient an impression on the progressing stages, when it already metastasizes to other organs.
A new device developed by a team of Israeli, American and British researchers can reverse this sad picture, revealing lung cancer at its earliest stages. Unlike other diagnostic methods that imply irradiation during imaging or surgical intervention, the new development is simple and effective.
The breathing tube, called "NaNose" (NaNose), was developed by Professor Nir Peled, the leading oncologist pulmonologist at the Herzliya Medical Center. The mechanism of action is a special nano-chip, built into the usual tubule for the breath test. The study involved 358 patients who are either at risk for lung cancer or who are already ill.
Professor Peled describes the results of the study: "Our Nanouz detected lung cancer with an accuracy of 90%, even in cases where the formation in the lungs was the smallest and did not allow a biopsy. In four out of five cases, the device even successfully differentiated between benign and malignant lesions of the lungs. "
Professor Nir Peled is known for his unique approach and sincere attitude to each patient. On his initiative, the Herzliya Medical Center developed a fast and effective program for the early diagnosis and prevention of lung cancer. Patients with advanced lung cancer Professor Peled offers molecular diagnostics and selects an individual targeted therapy plan.
"Herzliya Medical Center" is the leading private clinic in Israel, in which the best specialists of the country are accepted and thousands of operations are conducted annually. The clinic accepts foreign patients and offers them top-level services, accompanied by a Russian-speaking case manager and hospitalization in a private room at the level of a five-star hotel.
If you want to learn more about the diagnosis and treatment in the leading Israeli clinic "Herzliya Medical Center", click here.
Thanks to the introduction of innovative methods of diagnosis, birth in Israel is carried out by a natural physiological way, but under the vigilant control of high-tech equipment and qualified specialists.
"Epigenetic" combination therapy can restore the activity of an anti-cancer gene at a late stage of lung cancer. Scientists have tested a new type of treatment aimed at suppressing the activity of a gene that promotes the growth of cancer cells.
Testing drugs for the prevention of lung cancer takes a considerable amount of time. The results have to wait five, ten or even fifteen years. Unfortunately, at the moment there is no way to quickly identify the effectiveness of a given medicine.
You are reporting a typo in the following text:
Simply click the "Send typo report" button to complete the report. You can also include a comment.